Sartorius Stedim Biotech und Repligen Corporation gehen Partnerschaft zur Einführung perfusionsfähiger Bioreaktoren der nächsten Generation ein

Entwicklungszusammenarbeit stattet BIOSTAT® STR-Bioreaktoren von Sartorius Stedim Biotech mit der XCell™ ATF-Steuerungstechnologie zur Zellrückhaltung von Repligen ausKunden profitieren von vereinfachten, skalierbaren Lösungen für intensivierte Zellkulturen GÖTTINGEN, Deutschland und WALTHAM, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) — Sartorius Stedim Biotech (SSB) (Euronext: DIM), ein führender internationaler Anbieter für die Biopharmabranche, und […] Lire la suite »

Datawatch Panopticon Joins Confluent Partner Program

BEDFORD, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) — Datawatch Corporation (NASDAQ-CM: DWCH) today announced that it has become a Technology Partner in the Confluent Partner Program. Confluent has verified that the Panopticon Streaming Analytics platform properly integrates with and supports Confluent Platform and Apache Kafka® along with Kafka’s Streams API. […] Lire la suite »

electroCore to Present Additional Research for Non-invasive Vagus Nerve Stimulation in Headache Disorders at the 17th Biennial Migraine Trust International Symposium

BASKING RIDGE, N.J., Sept. 05, 2018 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that seven abstracts and an oral presentation featuring non-invasive vagus nerve stimulation (nVNS) across two primary headache disorders will be presented at the 17th Migraine Trust International Symposium (MTIS) (September 06-09, […] Lire la suite »